IL6 and heavy chain disease: The HCD group showed a higher cardiac IL-6 level (4760 ± 192.5 ng/mL versus 3760 ± 227.2 ng/mL, p < 0.026) (Fig. 5b), with an increasing trend of the cardiac IL-1β level when compared to the control group (Fig. 5c).